Journal of Cardiovascular Electrophysiology

Article	Citations
Long conduction time from the anterior left atrium to coronary sinus during entrainment pacing of a bi‐atrial tachycardia: What is the mechanism?	133
Issue Information	71
Bringing big data to vascular complications during atrial fibrillation ablation	70
The high‐density grid catheter: A safe adjunctive tool in pediatric and complex congenital heart disease patients	56
Focal and rotational drivers in persistent atrial fibrillation: Are we chasing ghosts?	53
Short or long‐coupled idiopathic ventricular fibrillation: Does the coupling interval really matter?	51
Radiofrequency ablation of persistent atrial fibrillation in a patient with situs inversus totalis and interrupted inferior vena cava	50
Pacemaker‐mediated reentrant arrhythmia facilitated by an atrial‐tracking leadless pacemaker	50
An irregular tachycardia: What is the mechanism?	41
Ultrasound‐guided vascular access for CIED implantation: A step‐by‐step guide	38
Letter to the Editor regarding: Impact of artificial intelligence arrhythmia mapping on time to first ablation, procedure duration, and fluoroscopy use	38
	38
Comments on “High Power Short Duration Temperature‐Controlled Radiofrequency Ablation for the Treatment of Outflow Tract Ventricular Arrhythmias”	38
Accessory Pathway Antegrade Electrophysiologic Features Among Wolff–Parkinson–White Patients: The Risk in Relation to the Location	37
Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis	37
Multielectrode Radiofrequency Balloon Catheter for Paroxysmal Atrial Fibrillation: Results From the Global, Multicenter, STELLAR Study	35
Elevated fibrosis burden as assessed by MRI predicts cryoballoon ablation failure	33
Narrow complex tachycardia with alternating atrial activation: What is the mechanism?	33
Regarding the article “automatic identification of ablation targets in persistent atrial fibrillation: Initial experience with a new mapping tool”	31
Central venus cannulation during cardiac surgery as a possible new additional risk factor for late post‐operative atrial fibrillation insurgence	31
A Case of Ventricular Premature Contractions With Multiple Morphologies Reproduced by a Single Ventricular Extrastimulus With Different Coupling Intervals	31
“Pill‐in‐Pocket” anticoagulation for stroke prevention in atrial fibrillation	30
Pulmonary vein reconnection and repeat ablation characteristics following cryoballoon‐ compared to radiofrequency‐based pulmonary vein isolation	29
Clinical relevance of the blanking period on late recurrence after catheter ablation of atrial fibrillation	29
Comparison of Integrated 3D Electroanatomic Mapping and Conventional Mapping Systems for Pentaspline Pulsed Field Ablation of Atrial Fibrillation	29

Targeted ablation of residual pulmonary vein potentials in atrial fibrillation ablation through ultra‐high‐density mapping: Insights from the CHARISMA registry	29
Step‐by‐step recommendations utilizing four‐dimensional intracardiac echocardiography in left atrial appendage procedures	28
Novel streamlined technique for left atrial appendage closure using a radiofrequency wire‐based large access system	28
Sotalol in neonates for arrhythmias: Dosing, safety, and efficacy	28
Electrical storm after left ventricular assist device (LVAD) implantation	27
Ablation of atrial fibrillation beyond pulmonary vein isolation: Do additional ablation lesions impact left atrial function?	27
Evaluation of microembolic signals on carotid ultrasound during pulmonary vein isolation with high‐power short‐duration and cryoballoon ablations: When and where do bubble and solid emboli arise?	27
The Single‐Delayed‐Phase Contrast Computed Tomography Before Ablation to Reduce Radiation Exposure Without Compromising Diagnostic Pulmonary Vein Accuracy	26
Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease	25
A 15‐year follow‐up study of radiofrequency catheter ablation for atrial fibrillation in patients with tachycardia‐bradycardia syndrome	25
Age, Frailty, and Outcomes After Atrial Fibrillation Ablation: A Nationwide Cohort Study	25
When Propensity Score Does Not Always Match? Letter to the Editor Regarding “Pulsed Field Ablation for Persistent Atrial Fibrillation in EU‐PORIA Registry”	25
Prognostic Value of Small Coved‐Type ST‐Segment Area in Patients With Spontaneous Type 1 Brugada Syndrome	25
Incidence and Predictors of Pacing‐Induced Cardiomyopathy in Paced Patients Undergoing Attempted Left Bundle Branch Area Pacing	25
First clinical data on artificial intelligence‐guided catheter ablation in long‐standing persistent atrial fibrillation	24
Long‐Term Impact of GLP‐1 Receptor Agonists on AF Recurrence After Ablation in Obese Patients	24
Very High‐Power Short‐Duration Ablation for Premature Ventricular Complexes From Sites With Suboptimal Catheter Stability	24
Corrigendum	23
	23
Issue Information	22
Electrogram‐based AF ablation: finally, reproducibility!	21
Convergent ablation for persistent atrial fibrillation: A UK multicentre perspective	21
Cardiopulmonary Exercise Testing‐Guided Beta‐Blocker Dosing in Long QT Syndrome: Genotype, Methodology, and Adherence Concerns	21
Issue Information	21
Impact of remote reprogramming on insertable cardiac monitors alert burden	20
Ventricular arrhythmias in patients with bicuspid aortic valves	20
Predicting ventricular arrhythmia inducibility in ajmaline‐induced Brugada type I pattern: Validation of the dST‐Tiso interval	20
Feasibility of a novel atrial mechanical sensing method for leadless atrioventricular synchronous pacing	20
Factors Affecting the Impact of LBBBP on Ventricular Electrical Activation	20
Authors' response to letter to the editor regarding relationship between sodium‐glucose cotransporter two inhibitors and atrial fibrillation recurrence after pulmonary vein isolation in patients with	19
In which patients with heart failure should ablation of atrial fibrillation not be performed?	19
Lesion monitoring parameters as predictors of atrial arrhythmia recurrence after catheter ablation in persistent AF: A DECAAF II sub‐analysis	19
Reply to: “Seize the day….s(e)ize the device: The emerging imaging modality to improve left atrial appendage device sizing”	19
Left Atrial Function and Strain Assessed by Three‐Dimensional Echocardiography as Factors Associated With Atrial Fibrillation Recurrence After Pulmonary Vein Ablation	19
	19
	19
Removal of an active fixation coronary sinus pacing lead 5 years postimplant: A case report	18
Leadless Versus Single Chamber Pacemakers: An Analysis From the National Readmissions Database of Adverse Outcomes	18
The Association Between Newly Acquired Permanent Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement and New‐Onset Cardiomyopathy	18
Durability of left bundle branch area pacing	18
Ventricular Tachycardia Ablation in Patients With Severely Decreased Left Ventricular Ejection Fraction	17
COVID‐19 vaccination and atrial fibrillation: When pandemics collide	17
Nonlinear Relationship Between Left Atrial Volume Measured by Computed Tomography and Recurrent Atrial Arrhythmias in Patients Undergoing Catheter Ablation for Atrial Fibrillation	17
Irreversible electroporation for cardiac ablation: Optimizing cell type‐specific effects	17
Visualization of Electrophysiologically Defined Superior Vena Cava‐Right Atrium Junction With High‐Resolution Mapping Using Atrial Extrastimulus	17
Treating syncope without drugs: Standing still, exercising hard, or simply the “expert's touch”?	17
Managing ventricular arrhythmias and implantable cardiac defibrillator shocks after left ventricular assist device implantation	16
Correction to “Comparison of treatment outcomes between convergent procedure and catheter ablation for paroxysmal atrial fibrillation evaluated with implantable loop recorder monitoring”	16
“Function follows form”: Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis	16
Impact of omitting the intravenous heparin bolus on outcomes of leadless pacemaker implantation	16

Practical and systematic approach using the steerable catheter and stylet‐driven lead to deliver safe and effective left bundle branch area pacing	16
Clinical Predictors of Recurrent Cavotricuspid Isthmus Flutter After Catheter Ablation in Patients With Dextro‐Transposition of the Great Arteries	15
Impact of left atrial low‐voltage areas during initial ablation procedures on very late recurrence of atrial fibrillation	15
Intermittent Ventricular Pre‐Excitation: Clinical Features and Electrophysiological Properties	15
Characteristics of successful reactive atrial‐based antitachycardia pacing in patients with cardiac implantable electronic devices: History of catheter ablation of atrial fibrillation as a predictor o	15
Beyond Catheter Design: The Overlooked Role of Fluids in Pulsed Field Ablation Hemolysis	15
Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome	14
Establishing electroporation thresholds for targeted cell specific cardiac ablation in a 2D culture model	14
Temporal and spatial pacemap parameters for identification of cardiac surfaces with critical sites for ventricular tachycardia	14
Intravascular Lithotripsy to Facilitate Extraction of Very Old Cardiac Implantable Electronic Devices Leads	14
Simultaneous narrow and wide QRS complex tachycardia: Misdiagnosis or missed diagnosis?	14
Comparison of Two Different Pulsed Field Ablation Systems: The Dual Pulse System Study	14
Same‐day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry	14
Impedance‐decline‐guide power control long application time bipolar radiofrequency catheter ablation	14
Costs, efficiency, and patient‐reported outcomes associated with suture‐mediated percutaneous closure for atrial fibrillation ablation: Secondary analysis of a randomized clinical trial	13
Temporary Restoration of Sinus Rhythm Improves Outcomes of Catheter Ablation for Longstanding Persistent Atrial Fibrillation	13
Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR ICE study	13
A device‐related fistula between coronary artery and left atrial appendage following left atrial appendage closure: Case presentation	13
Outcomes of Exclusive 50 W High Power, 5 s Ablation Close to the Esophagus in Pulmonary Vein Isolation	13
Two‐To‐One Conduction Between the Inside and Outside of the Left Atrial Posterior Wall During Atrial Tachycardia: What Is the Mechanism?	13
Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis	13
Introduction of the Low Voltage Bridge Mapping for the AVNRT RF Ablation in Children – Early Follow‐Up Results	13
Ethanol Infusion Therapy for Incessant Atrial Tachycardia Arising From the Distal Left Atrial Appendage	13
Activation signatures for identifying critical isthmi of ventricular tachyarrhythmias	13
Ventricular arrhythmias in patients with prior aortic valve intervention: Characteristics, ablation and outcomes	13
Initial Pre‐Clinical Evaluation of the Augmented Ultra‐Low Temperature Cryoablation Catheter for Ventricular Ablations	13
Colchicine usage for prevention of post atrial fibrillation ablation pericarditis in patients undergoing high‐power short‐duration ablation	13
Is esophageal temperature management needed during cryoballoon ablation for atrial fibrillation?	13
Issue Information	13
Sensing of concealed ventricular extrasystoles by pacemakers. Fifty years later	13
Detailed mechanism of difficulty in cryoablation for atrial fibrillation in patients with very severe obesity	12
Exploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non‐Actionable Alerts and Assessing Clinical Outcomes	12
Double atrial potentials in the coronary sinus: What is the mechanism?	12
Rationale and Design of the InsightPFA Trial: A Prospective, Multicenter, Randomized Controlled Trial of the Irreversible Electroporation‐Based Pulsed Field Ablation Versus Radiofrequency Ablation in	12
Patient reported QOL and EV‐ICD: Response to letter from Kataoka and Imamura (2024)	12
	12
Idiopathic Premature Ventricular Complexes Originating From Right Ventricular False Tendons	12
Dilated, hypertrophic or fibrotic: On the road to a noninvasive atrial substrate classification of atrial fibrillation	12
Editorial to: Efficacy and safety of a novel temperature‐controlled catheter for cavotricuspid isthmus ablation	12
Quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator	12
Ventricular tachycardia ablation with pentaspline pulsed field technology in two patients with ischemic cardiomyopathy	12
Removal of EVICD Leads Are Specialized Tools Required?	12
Issue Information	12
Incidence, Predictors, and Outcomes With Ventricular Arrhythmias in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Analysis	11
Left Atrial Wall Thickness Measured by a Machine Learning Method Predicts AF Recurrence After Pulmonary Vein Isolation	11
Combined approach of high‐power and very high‐power, short‐duration ablation in superior vena cava isolation	11
Lesion Depth Optimization in High‐Power Radiofrequency Ablation: Evaluating Single High‐Power and Combined Very High‐Power Applications	11
Cover Image, Volume 36, Issue 8	11
Electrocardiographic Characteristics of Ventricular Arrhythmias Originating From High Right Ventricular Outflow Tract and Pulmonary Artery	11
Surpoint algorithm for improved guidance of ablation for ventricular tachycardia (SURFIRE‐VT): A pilot study	11
Letter to the Editor: Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation	11
The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest	11
Noninvasive ECG imaging of the intrinsic atrial pacemaker and atrial activation in surgically repaired or palliated congenital heart disease	11
Correction to “Physiological Pacing: Historical Review With an Eye to the Future”	11
An Interesting Response During Left Bundle Branch Area Pacing: Electrophysiological Insights	11
Propensity‐Matched Five‐Year Cardiac Resynchronization Therapy Outcomes in Sarcoidosis With Heart Failure	11
Cost‐Utility Analysis of Left Bundle Branch Area Versus Biventricular Pacing for Cardiac Resynchronization Therapy: A Multicenter, Prospective, Quasi‐Experimental Study	11
Early Recurrence of Atrial Tachyarrhythmias After Pulsed Field Ablation: New Technologies, Same (Blanking) Problems	10
“Piece by Piece” understanding of patient reported QOL and EV‐ICD: Response to letter from Vicentini and Rodorf	10
Safety and Efficacy of LockeT Suture Retention Device for Large‐Bore Venous Access Closure	10
Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues	10
Comparison of HEMOlysis Markers Among Three Pulsed Field Ablation Systems: HEMO‐PFA Study	10
Left Ventricular and Biventricular Multipoint Pacing With Dynamic Atrioventricular Delays: 6‐Month Cardiac Resynchronization Therapy Response	10
Mind the gap: Recurrence of ventricular pre‐excitation after accessory pathway effective refractory period with short coupled paced stimuli	10
Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy	10
Widening the scope of complex cardiac implantable electronic devices implant considerations: Time for an integrated multidisciplinary approach	10
Limitation of Unipolar Electrograms in Guiding Successful RFCA of Idiopathic Ventricular Arrhythmias Associated With Discrete Pre‐Potential	10
Leadless versus transvenous single‐chamber ventricular pacemakers: 3 year follow‐up of the Micra CED study	10
High‐Power Short‐Duration Ablation Versus Conventional Power Ablation in Pulmonary Vein Isolation in Patients With Atrial Fibrillation: An Updated Systematic Review and Meta‐Analysis of Randomized Con	10
Impact of Sodium‐Glucose Co‐Transporter 2 Inhibitors on Atrial Fibrillation Recurrence Post‐Catheter Ablation Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis	10
Differential gap location after radiofrequency versus cryoballoon pulmonary vein isolation: Insights from a randomized trial with protocol‐mandated repeat procedure	10
	10
Inflammatory reaction to TYRX antibacterial envelope mimicking infection	10
Initial clinical experience of pulmonary vein isolation using the ultra‐low temperature cryoablation catheter for patients with atrial fibrillation	10
Safety of Ablation Within the Coronary Venous Sinus in Pediatric Patients	10
	10
Ultrasound guidance for femoral venous access in patients undergoing pulmonary vein isolation: A quasi‐randomized study	10
Cover Image, Volume 35, Issue 12	10
Left atrial appendage dimension predicts elevated brain natriuretic peptide in nonvalvular atrial fibrillation. Authors response	10
Predictors of low‐voltage zones in patients with persistent atrial fibrillation eligible for catheter ablation: An observational study	9

Incidence and Characteristics of Superior Vena Cava Impact After Pulsed‐Field Ablation of the Right Pulmonary Veins	9
Tricuspid valve damage and improvement following transvenous lead extraction procedures	9
Outcomes of Transvenous Lead Removal in Patients With Prior Mediastinal Radiation	9
Pulsed‐Field Ablation: What We Know and What We Don't	9
Incidental left atrial appendage isolation after catheter ablation of persistent atrial fibrillation: Mechanisms and long‐term risk of thromboembolism	9
Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long‐term outcomes in patients with and without structural heart disease	9
Acute Nonsustained Mitral Isthmus Block Obtained With Sphere‐9 Lattice‐Tip Catheter Completed With Vein of Marshall Ethanol Infusion	9
Cryoballoon for heart failure: Time to consider earlier	9
Impact of intracardiac echocardiography usage on the safety of cryoballoon atrial fibrillation ablation: Subanalysis of the prospective FREEZE cluster cohort study	9
Machine learning identifies esophageal luminal temperature patterns associated with thermal injury in catheter ablation for atrial fibrillation	9
Atrial Fibrillation Ablation During Hospitalization for Acute Heart Failure: Feasibility and Role of Pulsed Field Ablation	9
Difference in Cerebral Microembolization With Multielectrode Pentaspline or Variable‐Loop Circular PFA Systems	9
Early ablation of newly diagnosed paroxysmal atrial fibrillation (NEWPaAF) versus newly diagnosed persistent atrial fibrillation (NEWPeAF): Comparison of patient populations and ablation outcomes	9
Six‐Month Emergent Readmissions Following Hospitalization for Atrial Fibrillation Amid the Syrian Conflict: A Real‐World Observational Cohort Study	9
Early and late Watchman device migration and embolization: Insights from the NCDR LAAO registry	9
Efficacy and durability of posterior wall isolation with ethanol infusion into the vein of Marshall	9
Consistency of ablations with trainee and increasing independence during fellowship training—Analysis of ablation data by CARTONET	9
Urgent desensitization for severe amiodarone intolerance with a 12‐step protocol	9
The advantage of the mini‐electrode‐equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia	9
Quantitative assessment of transient autonomic modulation after single‐shot pulmonary vein isolation with pulsed‐field ablation	9
Initial Clinical Experience With a Novel 4D Intracardiac Echocardiographic Imaging and Guidance System in Catheter Ablation Procedures	9
Reply to “Challenges to the Claimed Safety and Feasibility of Atrial Fibrillation Ablation and Left Atrial Appendage Occlusion Without Onsite Cardiothoracic Surgery”	9
Endocardial Atrial Lesion Characteristics With Pentaspline Pulsed Field Ablation: Insights From Serial Mapping in Patients	9
Conduction System Pacing With Stylet Driven Leads: A Step‐By‐Step Guide to Implant	9
Metabolic effects of the left atrial appendage exclusion (the heart hormone study)	9
Precise Activation Within the Triangle of Koch: Insights from Ultra‐High‐Resolution Mapping and Cryoablation Terminating AVNRT	9
Association between temperature and air pollutants with atrial fibrillation presentations to emergency departments	9
Age and Clinically Actionable Events in Patients With Implantable Loop Recorders: Analysis of Multicenter Loop Recorder Registry	9
A novel single shot pulsed field ablation catheter: Where does it stand and where do we go from here?	8
Outcomes of vascular closure devices for femoral venous hemostasis following catheter ablation of atrial fibrillation	8
Left atrial epicardial adipose tissue exacerbates electrical conduction disturbance in normal‐weight patients undergoing pulmonary vein isolation for atrial fibrillation	8
Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data	8
AMEN and ALARA—Remembering the dangers of the (new) technology of lesion formation	8
Raise‐up technique for the creation of left atrial roof lesion: A useful technique with cryoballoon for persistent atrial fibrillation	8
Pacing induced tricuspid regurgitation: Does the lead matter?	8
Pulsed Field Ablation Systems for Atrial Fibrillation	8
Successful ablation of a right concealed epicardial accessory pathway using ethanol infusion	8
Issue Information	8
Author Response to: Expanding the Biophysical Insights Into Esophageal Heating During Radiofrequency Ablation	8
Artificial Intelligence‐Enabled Short‐Term Ambulatory Monitoring ECG During Sinus Rhythm for Prediction of Hidden Atrial Fibrillation	8
Association between high‐density mapping of atypical atrial flutter, clinical outcomes and healthcare utilization	8
Therapeutic Strategy for Patients With Heart Failure and Atrial Fibrillation	8
Pulsed field ablation in patients with complex consecutive atrial tachycardia in conjunction with ultra‐high density mapping: Proof of concept	8
Comparison of three different approaches to very high‐power short‐duration ablation using the QDOT‐MICRO catheter	8
Watchman device migration and embolization: A report from the NCDR LAAO Registry	8
RETRACTION: A Comparison of Procedure‐Related Adverse Events Between Two Right Ventricular Leadless Pacemakers	8
The coronary sinus Marshall structure: From an anatomical ligament to an arrhythmogenic vein	8
Issue Information	8
Issue Information	8
Characteristics of Left Ventricular Endocardial Electroanatomic Voltage Mapping in Patients With Tachycardia‐Induced Cardiomyopathy	8
Left bundle branch area pacing using a lumenless lead for LBBAP: Safety and efficacy in a new use‐case	8
Efficacy of the peak frequency map for left atrial posterior wall isolation	8
Trends in Mortality Related to Atrial Fibrillation and Dementia in Older Adults in the United States: A 2000–2020 Analysis	8
Atrial fibrillation detection using insertable cardiac monitor after stroke: A real‐world cohort study	8
Significance of the local largest bipolar voltage for the optimized ablation strategy using very high‐power short duration mode	8
TEE versus ICE for LAAO: Is ICE just as nice?	8
Epicardial mapping and ablation of biatrial macroreentrant tachycardia via Bachmann's bundle	8
Same day discharge after transvenous lead extraction: Balancing safety and efficiency	8
Issue Information	8
Feasibility and Clinical Efficacy of Focal Pulsed Field Ablation in Patients With Non‐Pulmonary Vein Triggered Atrial Arrhythmia From the Superior Caval Vein	8
Impact of Emergent Physician Notifications from Mobile Cardiac Outpatient Telemetry on Patient Outcomes (The EP‐COT Trial)	7
Differences Between the Unipolar Versus Bipolar Potential‐Based Activation Maps of Ventricular Premature Contractions Arising From Ventricular Outflow Tracts	7
Conduction time around the mitral valve annulus has the potential to rule out postablation perimitral atrial tachycardia	7
Radiofrequency energy floats, and heat sinks: The effects of convective cooling on lesion formation	7
Issue Information	7
Acute Atrial Pacing Threshold Elevation in an Auricular Leadless Pacemaker During Monopolar Pulsed Field Ablation of the Right Inferior Pulmonary Vein: A First‐in‐Human Case	7
Left bundle branch area pacing using a lumenless lead: A systematic literature review and meta‐analysis	7
Reconsidering the Antiarrhythmic Role of Sodium–Glucose Cotransporter‐2 Inhibitors After Atrial Fibrillation Ablation	7
The role of cardiac surgeon in transvenous lead extraction: Experience from 3462 procedures	7
Changing the view: Preventing pneumothorax during transvenous pacemaker implantation	7
Development of a clinically relevant ex vivo model of cardiac ablation for testing of ablation catheters	7
Three‐Dimensional Mapping of the Left Atrial Wall Rather Than the Left Atrial Chamber	7
When Close Is Not Close Enough: Cardiomyopathy After Deep Septal Pacing	7
Thirty‐day mortality risk in patients following radiofrequency and cryoballoon ablation for atrial fibrillation across the entire nation of Poland: An 8‐year analysis from the National Health Fund of	7
Characteristics and outcome of wearable cardioverter‐defibrillator therapy stratified by gender: Insights from a multicenter international registry	7
Ventricular arrhythmias related to COVID‐19 infection and vaccination in patients with Brugada syndrome: The importance of a correct patient stratification	7
Fluoroless Mapping and Ablation With Integration of a Pentaspline Pulsed Field Catheter	7
Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique	7
Leadless cardiac ventricular pacing using helix fixation: Step‐by‐step guide to implantation	7
Ablating Misconceptions to Prevent Failure of Interpretation: Revisiting the CLAPHAF Study	7
Distribution of excitation recoverable myocardium after radiofrequency ablation and its relation to energy application time and irrigation	7
Effects of parameters on radiofrequency guidewire ablation: In vitro and in vivo experiments	7
Reply to Letter to Editor: How to Prevent Silent Cerebral Embolism During Left Ventricular Ablation	7
	7
Long‐Term Outcomes of Cryoballoon Pulmonary Vein Isolation Freeze Using a Modified ICE‐T Protocol With a Double 120 s Applications (ICE‐T 2 × 2)	7
Entrainment response during ventricular tachycardia originating from the para‐Hisian region: What is the mechanism?	7
Ex‐vivo histopathologic examination of irrigated radiofrequency ablation utilizing half‐normal saline of the human heart	7
Inferior lead QRS discordance on surface electrocardiogram predicting right anterior accessory pathways: A simplified approach	7
Vein of Marshall Ethanol Ablation as a Strategy for Recurrent Persistent Atrial Fibrillation	7
Preclinical evaluation of semi‐automated laser ablation for pulmonary vein isolation: A comparative study	7
Understanding Atrial Fibrillation Complexity Through the Lens of Turbulence Dynamics: Implications for Treatment Strategies	7
Association between residual unipolar voltage and arrhythmia recurrence after left atrial posterior wall isolation for persistent atrial fibrillation	7
Challenges in cardiac implantable electronic device surveillance: Insights from real‐world data	7
Peak frequency mapping of atypical atrial flutter	7
Low voltage area guided substrate modification in nonparoxysmal atrial fibrillation: A systematic review and meta‐analysis	7